Rocket Pharmaceuticals Inc
NASDAQ:RCKT

Watchlist Manager
Rocket Pharmaceuticals Inc Logo
Rocket Pharmaceuticals Inc
NASDAQ:RCKT
Watchlist
Price: 3.05 USD -3.48% Market Closed
Market Cap: 328.6m USD

Relative Value

There is not enough data to reliably calculate the relative value of RCKT.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RCKT Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.5
Forward
26.4
vs History
vs Industry
Median 3Y
-6.2
Median 5Y
-7.2
Industry
23.6
Forward
-1.3
vs History
vs Industry
Median 3Y
-7.7
Median 5Y
-9
Industry
20.2
vs History
vs Industry
Median 3Y
-7.3
Median 5Y
-8.6
Industry
22.9
vs History
95
vs Industry
41
Median 3Y
3.4
Median 5Y
3.7
Industry
2.8
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.7
Forward
2.1
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9.6
vs History
vs Industry
Median 3Y
-5
Median 5Y
-5.8
Industry
4.9
Forward
-0.1
vs History
vs Industry
Median 3Y
-4.9
Median 5Y
-5.6
Industry
4.9
Forward
-0.1
vs History
vs Industry
Median 3Y
-6.3
Median 5Y
-7.1
Industry
5.4
vs History
vs Industry
Median 3Y
-6
Median 5Y
-6.8
Industry
4
vs History
95
vs Industry
35
Median 3Y
7.2
Median 5Y
8.7
Industry
5.1

Multiples Across Competitors

RCKT Competitors Multiples
Rocket Pharmaceuticals Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Rocket Pharmaceuticals Inc
NASDAQ:RCKT
325.6m USD 0 -1.3 -0.1 -0.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 917 039.3 -161 202.7 -195 751.4 -193 517.7
US
Abbvie Inc
NYSE:ABBV
339.9B USD 5.9 81.8 15.5 23
US
Amgen Inc
NASDAQ:AMGN
159.1B USD 4.7 26.8 14.4 23.7
US
Gilead Sciences Inc
NASDAQ:GILD
137.3B USD 4.8 23 10 13.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
121.1B USD 10.9 -122.3 26.1 27.3
US
Epizyme Inc
F:EPE
94.1B EUR 2 077.1 -530 -577.1 -561.7
AU
CSL Ltd
ASX:CSL
116.7B AUD 5.1 28 17.3 21.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
61.2B USD 4.3 13.5 12.2 13.6
US
Seagen Inc
F:SGT
39.3B EUR 20 -61.4 -66.1 -59.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
41.3B USD 17.6 -153.1 -686.3 -343.9
P/S Multiple
Revenue Growth P/S to Growth
US
Rocket Pharmaceuticals Inc
NASDAQ:RCKT
Average P/S: 3 391 919
Not Available
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
33 917 039.3
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.9
8%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.7
4%
1.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.8
3%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10.9
10%
1.1
US
E
Epizyme Inc
F:EPE
2 077.1
N/A N/A
AU
CSL Ltd
ASX:CSL
5.1
7%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
4.3
4%
1.1
US
S
Seagen Inc
F:SGT
20
30%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
17.6
29%
0.6
P/E Multiple
Earnings Growth PEG
US
Rocket Pharmaceuticals Inc
NASDAQ:RCKT
Average P/E: 34.6
Negative Multiple: -1.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -161 202.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
81.8
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
26.8
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
23
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -122.3 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -530 N/A N/A
AU
CSL Ltd
ASX:CSL
28
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.5
7%
1.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.4 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -153.1 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Rocket Pharmaceuticals Inc
NASDAQ:RCKT
Average EV/EBITDA: 15.9
Negative Multiple: -0.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 751.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.5
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.4
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
10
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.1
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -577.1 N/A N/A
AU
CSL Ltd
ASX:CSL
17.3
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.2
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.1 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -686.3 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Rocket Pharmaceuticals Inc
NASDAQ:RCKT
Average EV/EBIT: 20.5
Negative Multiple: -0.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -193 517.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.7
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.8
11%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
27.3
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -561.7 N/A N/A
AU
CSL Ltd
ASX:CSL
21.6
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.6
11%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.7 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -343.9 N/A N/A